KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) EBT (2016 - 2025)

Historic EBT for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to -$3.4 million.

  • LifeMD's EBT rose 2562.86% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.3 million, marking a year-over-year increase of 25505.07%. This contributed to the annual value of $20.5 million for FY2024, which is 21750.09% up from last year.
  • As of Q3 2025, LifeMD's EBT stood at -$3.4 million, which was up 2562.86% from -$1.1 million recorded in Q2 2025.
  • LifeMD's 5-year EBT high stood at $36.5 million for Q4 2024, and its period low was -$18.0 million during Q4 2021.
  • In the last 5 years, LifeMD's EBT had a median value of -$6.6 million in 2024 and averaged -$5.7 million.
  • As far as peak fluctuations go, LifeMD's EBT crashed by 39397.89% in 2021, and later soared by 140479.77% in 2024.
  • LifeMD's EBT (Quarter) stood at -$18.0 million in 2021, then surged by 37.69% to -$11.2 million in 2022, then soared by 75.08% to -$2.8 million in 2023, then surged by 1404.8% to $36.5 million in 2024, then plummeted by 109.29% to -$3.4 million in 2025.
  • Its last three reported values are -$3.4 million in Q3 2025, -$1.1 million for Q2 2025, and $348067.0 during Q1 2025.